$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What should I do if I become drug-resistant after taking Temozolomide?
2026-02-01 22:25:32
Check Details
None
2026-02-01 22:25:32
Check Details
I have been taking Temozolomide for 2 years with grade 4 brain tumor.
2026-02-01 22:25:32
Check Details
Can Temozolomide shrink tumors?
2026-02-01 22:25:32
Check Details
Can most people afford Temozolomide?
2026-02-01 22:25:32
Check Details
The difference between domestic and imported Temozolomide
2026-02-01 22:25:32
Check Details
Temozolomide for the treatment of small cell lung cancer
2026-02-01 22:25:32
Check Details
Temozolomide concurrent chemoradiotherapy regimen
2026-02-01 22:25:32
Check Details
Temozolomide 60 kg dose calculation
2026-02-01 22:25:32
Check Details
Can Temozolomide cure glioma?
2026-02-01 22:25:32
Check Details
Temozolomide is generally effective after several courses of treatment
2026-02-01 22:25:32
Check Details
How long do Temozolomide side effects last?
2026-02-01 22:25:32
Check Details
1
2
...
241
242
243
244
245
246
247
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves First mRNA Flu Vaccine mFLUSIVA
2
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
3
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
4
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
5
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
6
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
7
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
8
ROS and Cancer: The Potential of Natural Antioxidants
9
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
10
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
11
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
12
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial